88 related articles for article (PubMed ID: 29680323)
1. The First Year of the AEVD Primary Cutaneous Lymphoma Registry.
Peñate Y; Servitje O; Machan S; Fernández-de-Misa R; Estrach MT; Acebo E; Mitxelena J; Ramón MD; Flórez A; Blanes M; Morillo M; Medina S; Bassas J; Zayas A; Espinosa P; Pérez A; Gónzalez-Romero N; Domínguez JD; Muniesa C; López Robles J; Combalia A; Yanguas I; Suh H; Polo-Rodríguez I; Bielsa I; Mateu A; Ferrer B; Descalzo MA; García-Doval I; Ortiz-Romero PL
Actas Dermosifiliogr (Engl Ed); 2018 Sep; 109(7):610-616. PubMed ID: 29680323
[TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous T-cell lymphoma: a review of the most common entities with focus on recent updates.
Saleh JS; Subtil A; Hristov AC
Hum Pathol; 2023 Oct; 140():75-100. PubMed ID: 37802757
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of cutaneous T-cell lymphomas: state of the art and a focus on the Italian Marche region.
Pileri A; Morsia E; Zengarini C; Torre E; Goteri G; Quaglino P; Pimpinelli N; Paulli M; Pileri SA; Zinzani PL; Rupoli S
Eur J Dermatol; 2023 Aug; 33(4):360-367. PubMed ID: 37823487
[TBL] [Abstract][Full Text] [Related]
4. Pediatric primary cutaneous anaplastic large-cell lymphoma with associated hypovitaminosis D.
Tung-Hahn E; Mogilevskiy V; Black E; Morgan M; Tung R
Arch Dermatol Res; 2023 Dec; 316(1):50. PubMed ID: 38108932
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of Primary Cutaneous Lymphoma in Italy: A Tertiary Care, Single-Center Study.
D'Onghia M; Cartocci A; Calabrese L; Maio D; Sirchio A; Erasti M; Tognetti L; Rubegni P; Bocchia M; Cencini E; Fabbri A; Cinotti E
Curr Oncol; 2023 Nov; 30(11):9813-9823. PubMed ID: 37999132
[TBL] [Abstract][Full Text] [Related]
6. Primary cutaneous T-cell lymphoma: a review of the most common entities with focus on recent updates.
Saleh JS; Subtil A; Hristov AC
Hum Pathol; 2023 Aug; 138():76-102. PubMed ID: 37307932
[TBL] [Abstract][Full Text] [Related]
7. Paediatric cutaneous lymphomas including rare subtypes: A 40-year experience at a tertiary referral centre.
Alberti-Violetti S; Avallone G; Colonna C; Tavoletti G; Venegoni L; Merlo V; Cambiaghi S; Marzano AV; Berti E; Cavalli R
J Eur Acad Dermatol Venereol; 2024 Apr; ():. PubMed ID: 38650545
[TBL] [Abstract][Full Text] [Related]
8. Cost of Treating Cutaneous T-Cell Lymphoma in Spain: Analysis of MICADOS Study Data by Disease Stage.
Navarro Matilla B; Ortiz Romero PL; Pujol Vallverdú RM; Combalia Escudero A; Zapata Paz I; González Barca E; Muniesa Montserrat C; Morillo Andújar M; Pérez Ferriols A; Román Curto C; Fernández de Misa Cabrera R; Hospital Gil M; Marín Niebla A; Rios Rull PJ; de la Cruz Vicente F; Izu Belloso RM; Martín García-Sancho A; Parera Amer ME; Córdoba Mascuñano R; Ramón Quiles MD; Saus Carreres A; Del Campo García R; Machan S; Viguera Ester P; Blanco Garnelo J
Actas Dermosifiliogr; 2024 Feb; 115(2):119-129. PubMed ID: 37689349
[TBL] [Abstract][Full Text] [Related]
9. Protocol for the Histologic Diagnosis of Cutaneous Melanoma: Consensus Statement of the Spanish Society of Pathology and the Spanish Academy of Dermatology and Venereology (AEDV) for the National Cutaneous Melanoma Registry.
Tejera-Vaquerizo A; Fernández-Figueras MT; Santos-Briz A; Ríos-Martín JJ; Monteagudo C; Fernández-Flores A; Requena C; Traves V; Descalzo-Gallego MA; Rodríguez-Peralto JL
Actas Dermosifiliogr (Engl Ed); 2021 Jan; 112(1):32-43. PubMed ID: 33038295
[TBL] [Abstract][Full Text] [Related]
10. Descriptive Analysis and Factors Influencing Survival in Patients With Primary Cutaneous Gamma-Delta T Cell Lymphoma. A Retrospective National Cancer Database Study.
Ashok Kumar P; Sivapiragasam A; Wang D; Huang D; Gentile T
Clin Lymphoma Myeloma Leuk; 2023 Dec; 23(12):897-904. PubMed ID: 37690902
[TBL] [Abstract][Full Text] [Related]
11. Risk of systemic lymphoma in patients with cutaneous CD30+ lymphoproliferative disorders: A single center retrospective cohort analysis.
Chen J; Martinez A; Shinohara MM
J Am Acad Dermatol; 2024 Mar; ():. PubMed ID: 38490370
[No Abstract] [Full Text] [Related]
12. Primary Cutaneous Gamma-Delta T Cell Lymphomas: A Case Series and Overview of the Literature.
Alberti-Violetti S; Maronese CA; Venegoni L; Merlo V; Berti E
Dermatopathology (Basel); 2021 Nov; 8(4):515-524. PubMed ID: 34842638
[TBL] [Abstract][Full Text] [Related]
13. Increased risk of sepsis-caused death in Black patients with primary cutaneous T-cell lymphoma and Burkitt lymphoma: A population study of the US SEER registry.
Wu Y; Kang K; Sun X; Niu T; Zhao A
J Am Acad Dermatol; 2024 Feb; 90(2):e75-e78. PubMed ID: 37802184
[No Abstract] [Full Text] [Related]
14. Regression of CD30-positive large cell transformation arising on patch lesion of early mycosis fungoides.
Kubo N; Itoh M; Watanabe Y; Nobeyama Y; Asahina A
Clin Case Rep; 2020 Dec; 8(12):2418-2422. PubMed ID: 33363752
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of autoimmune diseases in cutaneous B-cell lymphoma: A retrospective cross sectional analysis.
Xiang D; Perlman K; Brumbaugh B; Reardon R; Barnes J; Patel C; Jain S; Chen ST
J Am Acad Dermatol; 2024 Jan; 90(1):177-179. PubMed ID: 37730019
[No Abstract] [Full Text] [Related]
16. Evaluation of Quality of Life and Treatment Satisfaction in Newly Diagnosed Cutaneous T-Cell Lymphoma Patients.
Ottevanger R; van Beugen S; Kersten JM; Evers AWM; Vermeer MH; Willemze R; Quint KD
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473299
[TBL] [Abstract][Full Text] [Related]
17. Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders (SMPLPD), demographical, clinical, therapeutic and prognostic aspects: a retrospective monocentric analysis.
Zengarini C; Guglielmo A; Bandini G; Filippini A; Mussi M; Agostinelli C; Sabattini E; Piraccini BM; Pileri A
Clin Exp Dermatol; 2024 May; ():. PubMed ID: 38738503
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
